Years of petitioning the DEA to remove cannabis from the controlled substance act have yielded no positive results, in spite of its proven and established therapeutic potential.

Imagine pushing for marijuana legislation for decades, just for a drug produced from a more potent and harmful controlled substance to receive more support from the DEA.

Very few people would have guessed that the “cocaine versus cannabis” discussion would come to light this year, and fewer still would have guessed that it would be the Drug Enforcement Administration (DEA) working tirelessly to see that a cocaine-derived drug is rescheduled before cannabis on a federal level.

View the full article at hightimes.com